1. Home/
  2. Compounds/
  3. SNX-2112:bortezomib (250:1 mol/mol)

SNX-2112:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2SNX-2112:bortezomib (250:1 mol/mol)
PharmacoGx SNX-2112:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to SNX-2112:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA COL6A6 CTRPv2 pan-cancer AAC 0.098 0.01
mRNA MCAT CTRPv2 pan-cancer AAC 0.08 0.01
mRNA MLF1 CTRPv2 pan-cancer AAC -0.088 0.01
mRNA SNW1 CTRPv2 pan-cancer AAC 0.084 0.01
mRNA RHEB CTRPv2 pan-cancer AAC -0.093 0.01
mRNA MAF1 CTRPv2 pan-cancer AAC -0.083 0.01
mRNA GDF6 CTRPv2 pan-cancer AAC 0.087 0.01
mRNA NDP CTRPv2 pan-cancer AAC -0.087 0.01
mRNA CECR6 CTRPv2 pan-cancer AAC 0.08 0.01
mRNA CTIF CTRPv2 pan-cancer AAC -0.088 0.01
Download CSV